$175.00
Retatrutide is an investigational metabolic peptide being studied for weight loss and type 2 diabetes. It is not yet FDA-approved and is still in clinical trials.
Semaglutide 5mg (Ozempic) (Bacteriostatic water not included)
Availability: In Stock
Retatrutide is an investigational metabolic peptide being studied for weight loss and type 2 diabetes. It is not yet FDA-approved and is still in clinical trials.
Retatrutide is known as a triple hormone receptor agonist, meaning it activates:
GLP-1 receptor โ appetite suppression, improved insulin response
GIP receptor โ enhances insulin sensitivity
Glucagon receptor โ increases energy expenditure & fat burning
This triple action is what makes it different from drugs like:
Semaglutide
Tirzepatide
Retatrutide adds glucagon stimulation, which may increase metabolic rate more significantly.
In early trials:
Participants lost up to 24%+ body weight
Significant fat mass reduction
Improved blood sugar control
These results are among the highest seen in obesity medications to date.
In studies, dosing is gradually titrated to reduce side effects.
10mg would be considered a higher dose tier in research settings.
Because it is still experimental:
Quality and purity vary widely outside of regulated trials
Dosing protocols are not standardized
Long-term safety data is limited
Nausea
Vomiting
Diarrhea
Appetite suppression (can be strong)
Increased heart rate (due to glucagon activity)
Semaglutide 5mg (Ozempic) (Bacteriostatic water not included)
Reviews
There are no reviews yet.